Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Membrane phenotypic studies in B cell lymphoproliferative disorders.

C S Scott, H J Limbert, I D MacKarill

    Journal of Clinical Pathology
    |September 1, 1985
    PubMed
    Summary

    This study phenotypically characterized 398 B cell lymphoproliferative diseases. Findings suggest distinct immunophenotypic patterns can reliably classify these disorders, including chronic lymphocytic leukaemia (CLL) and prolymphocytic leukaemia (PLL).

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lineage-Specific Monocytic Esterase, a Distinct Marker for Leukemias of Monocytic Origin: Cytochemical, Isoenzymatic and Biochemical Features.

    Leukemia & lymphoma·2016
    Same author

    T-Cell Membrane CD45RA (2H4) and CD45RO (UCHL1) Determinants: I, Diverse Patterns of Expression in Mature (Post-Thymic) T-Cell Proliferations.

    Leukemia & lymphoma·2016
    Same author

    T-Cell Membrane CD45RA (2H4) and CD45RO (UCHL1) Determinants: II, Aberrant HLA-ABC Expression by CD45RA and CD45RO Cell Subpopulations of Mature CD4(+) T-Cell Leukaemias.

    Leukemia & lymphoma·2016
    Same author

    Patterns of Membrane Antigen Expression by AML Blasts: Quantitation and Histogram Analysis.

    Leukemia & lymphoma·2016
    Same author

    DNA Genotypic Conservation During Phenotypic Switch from T-cell Acute Lymphoblastic Leukaemia to Acute Myeloblastic Leukaemia.

    Leukemia & lymphoma·2016
    Same author

    Yorkshire Case Control Study of Leukaemias and Lymphomas Parallel Multivariate Analyses of Seven Disease Categories.

    Leukemia & lymphoma·2016

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • B cell lymphoproliferative diseases encompass a range of hematologic malignancies.
    • Accurate classification is crucial for diagnosis, prognosis, and treatment selection.
    • Phenotypic characterization aids in distinguishing between different B cell leukemia and lymphoma subtypes.

    Purpose of the Study:

    • To phenotypically characterize a large cohort of B cell lymphoproliferative diseases.
    • To examine the relationships between chronic lymphocytic leukaemia (CLL), prolymphocytic leukaemia (PLL), and related variants.
    • To establish the reactivity of specific monoclonal antibodies, including FMC7 and T1, in B cell disorders.

    Main Methods:

    • Phenotypic characterization of 398 cases using membrane mouse red blood cell (MRBC) receptor, surface immunoglobulin, common acute lymphoblastic leukaemia (CALLA) antigen, and FMC7 and T1 monoclonal antibodies.

    Related Experiment Videos

  • Comparative analysis of immunophenotypic profiles to delineate disease subtypes.
  • Assessment of antibody reactivity in various B cell malignancies.

    • Main Results:

    • Most B cell lymphoproliferative diseases exhibited distinct phenotypic patterns despite some heterogeneity.
    • The expression of FMC7 was particularly informative in differentiating between CLL, PLL, and their variants.
    • The reactivity of the TU1 monoclonal antibody was established across different B cell disorders.

    Conclusions:

    • Immunophenotypic analysis provides a reproducible method for classifying B cell lymphoproliferative diseases.
    • Distinct phenotypic profiles support the classification of entities like CLL and PLL.
    • These findings offer a reliable basis for the diagnostic classification of B cell malignancies.